Metropolitan Life Insurance Company (MetLife)’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-977
| Closed | -$2.98K | – | 1494 |
|
|
2024
Q1 | $2.98K | Sell |
977
-2,310
| -70% | -$7.05K | ﹤0.01% | 2278 |
|
|
2023
Q4 | $10.6K | Hold |
3,287
| – | – | ﹤0.01% | 2160 |
|
|
2023
Q3 | $12.6K | Hold |
3,287
| – | – | ﹤0.01% | 2111 |
|
|
2023
Q2 | $10.8K | Buy |
+3,287
| New | +$10.8K | ﹤0.01% | 2262 |
|
|
2020
Q4 | – | Sell |
-7,248
| Closed | -$41.6K | – | 2562 |
|
|
2020
Q3 | $41.6K | Sell |
7,248
-7,212
| -50% | -$41.4K | ﹤0.01% | 2483 |
|
|
2020
Q2 | $107K | Buy |
+14,460
| New | +$107K | ﹤0.01% | 2224 |
|